Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI Study.
Roberts JA, Stove V, De Waele JJ, Sipinkoski B, McWhinney B, Ungerer JP, Akova M, Bassetti M, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J; DALI Study Authors.
Roberts JA, et al.
Int J Antimicrob Agents. 2014 May;43(5):423-30. doi: 10.1016/j.ijantimicag.2014.01.023. Epub 2014 Feb 22.
Int J Antimicrob Agents. 2014.
PMID: 24630304